[go: up one dir, main page]

MX2016006165A - Composiciones y metodos para valorar la funcion intestinal. - Google Patents

Composiciones y metodos para valorar la funcion intestinal.

Info

Publication number
MX2016006165A
MX2016006165A MX2016006165A MX2016006165A MX2016006165A MX 2016006165 A MX2016006165 A MX 2016006165A MX 2016006165 A MX2016006165 A MX 2016006165A MX 2016006165 A MX2016006165 A MX 2016006165A MX 2016006165 A MX2016006165 A MX 2016006165A
Authority
MX
Mexico
Prior art keywords
compositions
methods
gut function
assessing gut
assessing
Prior art date
Application number
MX2016006165A
Other languages
English (en)
Other versions
MX381200B (es
Inventor
B Dorshow Richard
J Hanley Steven
I Tarr Phillip
Original Assignee
B Dorshow Richard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by B Dorshow Richard filed Critical B Dorshow Richard
Publication of MX2016006165A publication Critical patent/MX2016006165A/es
Publication of MX381200B publication Critical patent/MX381200B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0052—Small organic molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

Se dan a conocer composiciones y métodos para valorar la función intestinal. Los mismos se diseñan para proporcionar una valoración exacta, rápida, en el centro de atención o colectiva de la disfunción entérica.
MX2016006165A 2013-11-11 2014-11-12 Composiciones y metodos para valorar la funcion intestinal. MX381200B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361902637P 2013-11-11 2013-11-11
PCT/US2014/065233 WO2015070256A1 (en) 2013-11-11 2014-11-12 Compositions and methods for assessing gut function

Publications (2)

Publication Number Publication Date
MX2016006165A true MX2016006165A (es) 2016-09-13
MX381200B MX381200B (es) 2025-03-12

Family

ID=53042261

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016006165A MX381200B (es) 2013-11-11 2014-11-12 Composiciones y metodos para valorar la funcion intestinal.

Country Status (10)

Country Link
US (4) US11077211B2 (es)
EP (2) EP3068399B1 (es)
JP (3) JP2016535102A (es)
CN (4) CN105873590B (es)
AU (1) AU2014346386B2 (es)
CA (1) CA2930387C (es)
IL (1) IL245602B2 (es)
MX (1) MX381200B (es)
NZ (1) NZ719971A (es)
WO (1) WO2015070256A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110312937B (zh) * 2017-01-19 2023-01-10 和田孝一郎 诊断肠黏膜通透性的诊断药、诊断方法及诊断装置
WO2018177381A1 (zh) * 2017-03-30 2018-10-04 合肥合源药业有限公司 乳果糖糖苷化合物、其制备方法及其用途
CN110545854A (zh) * 2017-10-27 2019-12-06 麦迪贝肯有限公司 用于肾功能确定的方法
EP3700578B8 (en) 2017-10-27 2026-01-07 MediBeacon Inc. Systems for renal function determination
CA3122681A1 (en) 2018-12-12 2020-06-18 Medibeacon Inc. Uses of transdermal glomerular filtration rate measurement in continuous renal replacement therapy
WO2021016133A1 (en) * 2019-07-19 2021-01-28 Washington University Particle-based method for defining a gut microbiota in humans or other animal species
GB202001336D0 (en) * 2020-01-31 2020-03-18 Imp College Innovations Ltd Methods for measuring gut permeability and gastric emptying rate
JP2023540433A (ja) * 2020-07-24 2023-09-25 メディビーコン，インク． 消化管機能を在宅で経皮的に評価するためのシステム及び方法
US20220326255A1 (en) * 2021-04-01 2022-10-13 Medibeacon Inc. Methods of monitoring mucosal healing

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6909912B2 (en) 2002-06-20 2005-06-21 University Of Florida Non-invasive perfusion monitor and system, specially configured oximeter probes, methods of using same, and covers for probes
US7430445B2 (en) 2003-04-24 2008-09-30 The Board Of Regents Of The University Of Texas System Noninvasive blood analysis by optical probing of the veins under the tongue
US20060095102A1 (en) 2003-09-17 2006-05-04 Thomas Perez Method and apparatus for sublingual application of light to blood
JP2008510806A (ja) 2004-08-26 2008-04-10 マリンクロッド・インコーポレイテッド 腎機能監視用の発光金属錯体
CN101087767A (zh) 2004-12-23 2007-12-12 马林克罗特公司 荧光吡嗪衍生物及其在评估肾功能中的使用方法
JP2008546798A (ja) * 2005-06-21 2008-12-25 マリンクロッド・インコーポレイテッド 光学的イメージング用の造影剤
AU2007261398A1 (en) * 2006-06-22 2007-12-27 Mallinckrodt Llc Pyrazine derivatives and uses thereof in renal monitoring
TWI327369B (en) * 2006-08-07 2010-07-11 Chipmos Technologies Inc Multichip stack package
CN1966086A (zh) * 2006-11-22 2007-05-23 重庆大学 一种获取药物消化道吸收特性的方法
CN101687040A (zh) * 2007-03-01 2010-03-31 马林克罗特公司 整合光活性的小分子及其用途
US8962530B2 (en) * 2007-06-27 2015-02-24 Regents Of The University Of Colorado Inflammatory bowel disease therapies
CA2695197C (en) 2007-07-31 2017-08-15 Mallinckrodt Inc. Integrated photoactive agents and uses thereof
WO2009021064A1 (en) 2007-08-06 2009-02-12 University Of Rochester Medical apparatuses incorporating dyes
CA2734936C (en) 2008-08-22 2018-06-05 Norbert Gretz Transcutaneous organ function measurement
US8697033B2 (en) 2008-12-17 2014-04-15 Medibeacon, LLC Modified pyrazine derivatives and uses thereof
US8628751B2 (en) 2009-04-16 2014-01-14 Medi Beacon Development, LLC Pyrazine derivatives for optical imaging and therapy
JP5817073B2 (ja) 2010-01-28 2015-11-18 国立大学法人三重大学 新規インドシアニン化合物を用いた診断用組成物及び分析方法
WO2011116142A1 (en) 2010-03-16 2011-09-22 Xiaojian Yang Method of using near infrared fluorescent dyes for imaging and targeting cancers
WO2011161220A1 (en) 2010-06-23 2011-12-29 Photocure Asa Hyperosmotic preparations comprising 5 -amino levulinic acid or derivative as photosensitizing agent
WO2012053306A1 (ja) 2010-10-22 2012-04-26 学校法人 福岡大学 胃上皮性腫瘍（腺腫・胃癌）の診断に有用な白色不透明物質を応用した内視鏡観察法および診断能改善組成物
US20120172678A1 (en) 2010-12-30 2012-07-05 Logan Robert J Systems and methods for monitoring and processing biometric data
WO2012149227A2 (en) 2011-04-26 2012-11-01 Incube Labs, Llc Mouthpiece for measurement of biometric data of a diver and underwater communication
WO2013106656A2 (en) 2012-01-12 2013-07-18 University Of Connecticut Methods of treating adverse intestinal effects of nonsteroidal anti-inflammatory drugs
US20130216482A1 (en) 2012-02-03 2013-08-22 The Board Of Regents Of The University Of Texas System Methods and compositions for non-invasive, dynamic imaging of intestinal motility

Also Published As

Publication number Publication date
JP2022009085A (ja) 2022-01-14
CN110251691A (zh) 2019-09-20
US20150147277A1 (en) 2015-05-28
US11285223B2 (en) 2022-03-29
IL245602B1 (en) 2023-11-01
EP3068399B1 (en) 2021-06-30
US12048751B2 (en) 2024-07-30
JP6961670B2 (ja) 2021-11-05
US11077211B2 (en) 2021-08-03
CN105873590B (zh) 2021-05-28
US20220241438A1 (en) 2022-08-04
US20190142976A1 (en) 2019-05-16
EP3733183A1 (en) 2020-11-04
EP3068399A1 (en) 2016-09-21
CN110237273A (zh) 2019-09-17
CA2930387C (en) 2023-02-14
CA2930387A1 (en) 2015-05-14
IL245602A0 (en) 2016-06-30
MX381200B (es) 2025-03-12
CN110237273B (zh) 2022-05-06
JP2016535102A (ja) 2016-11-10
AU2014346386B2 (en) 2020-04-02
US11285224B2 (en) 2022-03-29
EP3068399A4 (en) 2017-06-07
JP2020073517A (ja) 2020-05-14
IL245602B2 (en) 2024-03-01
WO2015070256A1 (en) 2015-05-14
CN112717146A (zh) 2021-04-30
AU2014346386A1 (en) 2016-06-02
US20190091348A1 (en) 2019-03-28
NZ719971A (en) 2022-05-27
CN105873590A (zh) 2016-08-17

Similar Documents

Publication Publication Date Title
MX2016006165A (es) Composiciones y metodos para valorar la funcion intestinal.
HUE063026T2 (hu) Eljárások és készítmények LDHA expressziójának gátlására
IL261163B (en) Crispr-cpf1-related methods, compositions and components for cancer immunotherapy
IL287607A (en) Preparations, kits and methods for inducing acquired cellular resistance using inducible stress proteins
IL255010A0 (en) Methods of increasing strength and functionality with gdf8 inhibitors
DK3390631T3 (da) Fremgangsmåder og sammensætninger til t-rna-baseret guide-rna-ekspression
DK3316909T3 (da) Anti-ntb-a-antistoffer og relaterede sammensætninger og fremgangsmåder
DK3245225T3 (da) Sammensætninger og fremgangsmåder til behandling og detektering af cancere
KR20180084891A (ko) 구조 조성물 및 방법
IL241112B (en) Methods and compositions for modification of hla
DK3125927T3 (da) Fremgangsmåder og sammensætninger til immunmodulering
DK3008168T3 (da) Sc-celler og sammensætninger og fremgangsmåde til dannelse deraf
IL257784A (en) Pharmaceutical composition used for reducing localised fat and use of pharmaceutical composition
IL253710B (en) Biomarkers for pancreatic cancer and kits and methods for detecting same
DK3324932T3 (da) Sammensætninger og fremgangsmåder for nanopartikel lyofile former
LT3288944T (lt) Imidazopirazinonai, kaip pde1 inhibitoriai
SG10201912464QA (en) Compositions, devices, and methods of ibs sensitivity testing
DK3123381T3 (da) Sammensætninger og fremgangsmåder relateret til diagnose af prostatacancer
DK3384287T3 (da) Forbedrede cytometriske analyser
FI3511422T3 (fi) Menetelmiä ja koostumuksia endometriooosin diagnosointia, ennustamista ja hoitoa varten
BR112016019822A2 (pt) Determinação enzimática de hba1c
IL257049A (en) Compositions and methods for measuring blood glucose levels
DK3013326T3 (da) Skaldannende sammensætninger til bløde kapsler og bløde kapsler
DK3364189T3 (da) Immunkromatografisk teststykke
ZA201607571B (en) Compositions and methods for detecting huanglongbing